OncoImmune, Inc. — Form D/A
OncoImmune, Inc. of ROCKVILLE, MD, a company, filed a Form D amendment with the SEC on 2020-05-22. The offering totals $3.0M, of which $3.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-05-22
- Form: D/A
- Accession: 0001695528-20-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $3.0M
- Minimum investment: $10K
- Investors: 3
- Date of first sale: 2020-03-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-364168
Issuer
- Name: OncoImmune, Inc.
- CIK: 0001695528
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 9430 Key West Ave., ROCKVILLE, MD, 208507
- Phone: 301-557-9119
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Gary Fanger | Director | Rockville, MD |
| Kun-Liang Guan | Director | Rockville, MD |
| Miao Hong | Director | Durham, NC |
| Yang Liu | Director | HONG KONG, K3 |
| KAREN LIU | Director | SAN DIEGO, CA |
| Martin Devenport | Executive Officer | Rockville, MD |
| Yang Liu | Executive Officer | HONG KONG, K3 |
| Pan Zheng | Executive Officer | Rockville, MD |
Other filings by this issuer (2)
More